BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 9325699)

  • 1. Dilution of urokinase used to treat thrombus formation in central venous catheters.
    Wiseman KC
    ANNA J; 1997 Aug; 24(4):457-8. PubMed ID: 9325699
    [No Abstract]   [Full Text] [Related]  

  • 2. Administering urokinase for catheter clearance.
    Mayo DJ
    Nursing; 1998 Dec; 28(12):50-2. PubMed ID: 9987281
    [No Abstract]   [Full Text] [Related]  

  • 3. Developing a protocol to prevent and treat pediatric central venous catheter occlusions.
    Harris JL; Maguire D
    J Intraven Nurs; 1999; 22(4):194-8. PubMed ID: 10476135
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prophylaxis with urokinase in pediatric oncology patients with central venous catheters.
    Kalmanti M; Germanakis J; Stiakaki E; Syfridaki C; Christidou A; Tsetis D; Vardas P; Charisis G
    Pediatr Hematol Oncol; 2002; 19(3):173-9. PubMed ID: 11936730
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intravenous catheter declotting: same outcomes with lower dose urokinase?
    Juvé ME
    J Infus Nurs; 2003; 26(4):245-51. PubMed ID: 12869858
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extravasation of thrombus into the aortic root: a complication following use of an infusion catheter for intragraft thrombolysis.
    Caputo RP; Cohen DJ; Baim DS; Kuntz RE
    Cathet Cardiovasc Diagn; 1996 Mar; 37(3):263-6. PubMed ID: 8974802
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prophylactic urokinase in the management of long-term venous access devices in children: a Children's Oncology Group study.
    Dillon PW; Jones GR; Bagnall-Reeb HA; Buckley JD; Wiener ES; Haase GM;
    J Clin Oncol; 2004 Jul; 22(13):2718-23. PubMed ID: 15226339
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Local intraarterial thrombolysis: in vitro comparison of various infusion catheters.
    Froelich JJ; Hoppe M; Freymann C; Thiel T; Wagner HJ; Barth KH; Klose KJ
    Cardiovasc Intervent Radiol; 1997; 20(5):369-76. PubMed ID: 9271648
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Importance of fibrin specificity in therapeutic thrombolysis and the rationale of using sequential and synergistic combinations of tissue plasminogen activator and pro-urokinase.
    Gurewich V
    Semin Thromb Hemost; 1989 Apr; 15(2):123-8. PubMed ID: 2501871
    [No Abstract]   [Full Text] [Related]  

  • 10. Selective infusion of urokinase and thrombectomy in the treatment of acute cerebral sinus thrombosis.
    Novak Z; Coldwell DM; Brega KE
    AJNR Am J Neuroradiol; 2000 Jan; 21(1):143-5. PubMed ID: 10669240
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lytic therapy in central venous catheters for hemodialysis.
    McFarland HF; Dinwiddie L; Ferrell J; Forloines-Lynn S
    Nephrol Nurs J; 2002 Aug; 29(4):355-60; quiz 361-2. PubMed ID: 12224368
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Continuous infusion of low-dose urokinase in the treatment of central venous catheter thrombosis in infants and children.
    Bagnall HA; Gomperts E; Atkinson JB
    Pediatrics; 1989 Jun; 83(6):963-6. PubMed ID: 2657625
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thrombosed central venous catheters: restoring function with 6-hour urokinase infusion after failure of bolus urokinase.
    Haire WD; Lieberman RP
    JPEN J Parenter Enteral Nutr; 1992; 16(2):129-32. PubMed ID: 1556806
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Catheter-directed thrombolysis for deep venous thrombosis.
    Raju S; Fountain T; McPherson SH
    J Miss State Med Assoc; 1998 Mar; 39(3):81-4. PubMed ID: 9538591
    [No Abstract]   [Full Text] [Related]  

  • 15. Effectiveness of low dose urokinase on dialysis catheter thrombolysis.
    Seddon PA; Hrinya MK; Gaynord MA; Lion CM; Mangold BM; Bruns FJ
    ASAIO J; 1998; 44(5):M559-61. PubMed ID: 9804494
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prototype therapeutic ultrasound emitting catheter for accelerating thrombolysis.
    Tachibana K; Tachibana S
    J Ultrasound Med; 1997 Aug; 16(8):529-35. PubMed ID: 9315208
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Method using urokinase and an antibiotic to avoid device removal in central venous catheter-related infections.
    Pession A; Castellini C; Prete A; Locatelli F; Urbini B; Paolucci G
    Med Pediatr Oncol; 2000 Oct; 35(4):434-5. PubMed ID: 11025478
    [No Abstract]   [Full Text] [Related]  

  • 18. Stability and sterility of recombinant tissue plasminogen activator at -30 degrees C.
    Wiernikowski JT; Crowther M; Clase CM; Ingram A; Andrew M; Chan AK
    Lancet; 2000 Jun; 355(9222):2221-2. PubMed ID: 10881901
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Extensive cerebral venous thrombosis resistant to heparin: local fibrinolysis with urokinase].
    Smadja D; Raynaud M; Mehdaoui H; Poey C; Drault JN; Ridarch A; Tixier F; Vernant JC; Mas JL
    Rev Neurol (Paris); 1997 May; 153(4):271-4. PubMed ID: 9296147
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Urokinase infusion for thrombosed catheters.
    Krzywda EA; Andris DA; Quebbeman EJ
    JPEN J Parenter Enteral Nutr; 1992; 16(6):596-7. PubMed ID: 1494226
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.